SKB264 in Combination With SKB118 for Non-Small Cell Lung Cancer

NCT07697586 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

206

Enrollment

INDUSTRY

Sponsor class

Conditions

NSCLC

Interventions

DRUG: SKB264+SKB118

Sponsor

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.